Previous 10 | Next 10 |
Image source: The Motley Fool. Theravance Biopharma, inc (NASDAQ: TBPH) Q2 2021 Earnings Call Aug 3, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript ...
Theravance Biopharma, Inc. (TBPH) Q2 2021 Earnings Conference Call August 03, 2021 05:00 PM ET Company Participants Gail Cohen - Vice President, Corporate Communications Rick Winningham - Chief Executive Officer Rick Graham - Senior Vice President, Development Frank Pasqualone - Chief Busines...
Theravance Biopharma (TBPH -1.4%) will have top-line results available for two key candidates later this quarter. The company is expecting phase 2b results for izencitinib, an oral pan-Janus kinase ("JAK") inhibitor for ulcerative colitis, and phase 3 results for ampreloxetine, a norepinephri...
Theravance Biopharma (NASDAQ:TBPH): Q2 GAAP EPS of -$0.80. Revenue of $12.91M (-13.9% Y/Y) Press Release For further details see: Theravance Biopharma reports Q2 results
Theravance Biopharma, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update - Company reiterates Q3 2021 top-line results timing for ampreloxetine Phase 3 and izencitinib Phase 2b in ulcerative colitis - Company's implied 35% share of YUPELRI® ...
Theravance Biopharma to Report Second Quarter 2021 Financial Results on August 3, 2021 PR Newswire DUBLIN, Ireland , July 20, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the dis...
JuSun/iStock via Getty Images During the week ended June 25, 2021, Healthcare sector rose 2.01% and Healthcare Select Sector SPDR ETF (XLV) gained 1.58% compared to weekly gain of 2.82% of S&P 500 ETF. Leading the top gainers pack was Atossa Therapeutics (ATO...
Gainers: Osmotica Pharmaceuticals (OSMT) +38%, Star Equity (STRR) +16%, Atossa Therapeutics (ATOS) +15%, Vor Biopharma (VOR) +12%, Rezolute (RZLT) +10%.Losers: Theravance Biopharma (TBPH) -8%, Corbus Pharmaceuticals (CRBP) -8%, Kaleido Bi...
primeimages/E+ via Getty Images Richard Branson's Virgin Galactic (SPCE) secured liftoff before the bell on Friday. Shares posted a dramatic advance on regulatory approval for its launch license. Used car dealer CarMax (KMX) rallied in Friday's pre-market as well, boosted by a strong ear...
Theravance Biopharma, Inc. Announces Pricing of Public Offering of Ordinary Shares PR Newswire DUBLIN , June 24, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma"), a diversified biopharmaceutical company primarily focuse...
News, Short Squeeze, Breakout and More Instantly...
Theravance Biopharma Inc. Company Name:
TBPH Stock Symbol:
NASDAQ Market:
Theravance Biopharma Inc. Website:
2024-06-15 00:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update PR Newswire Q1 2024 YUPELRI ® (revefenacin) net sales of $55.2 million , recognized by Viatris, increased 18% from Q1 2023 1 Viatris collaboratio...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...